Peter Fellner Joins Astex as Chairman
16 avr. 2002 02h33 HE
|
Astex Therapeutics
CAMBRIDGE, U.K., April 16, 2002 (PRIMEZONE) -- Astex Technology, the U.K. structure-based drug discovery company, today announced the appointment of Peter Fellner as non-executive Chairman of the...
Astex Announces Structure-Based Drug Discovery Collaboration with Aventis Pharmaceuticals
25 mars 2002 02h31 HE
|
Astex Therapeutics
CAMBRIDGE, U.K., March 25, 2002 (PRIMEZONE) -- Astex Technology, the private, structure-based drug discovery company, today announced a structural biology research agreement with Aventis...
Astex Receives Milestone Payment from AstraZeneca for Human Cytochrome P450 Program
25 mars 2002 02h15 HE
|
Astex Therapeutics
CAMBRIDGE, U.K., March 25, 2002 (PRIMEZONE) -- Astex Technology, the structure-based drug discovery company, announced today that it has received the first milestone payment from AstraZeneca AB, as...
Astex Appoints Director of Biophysics
20 févr. 2002 03h30 HE
|
Astex Therapeutics
CAMBRIDGE, U.K., Feb. 20, 2002 (PRIMEZONE) -- Astex Technology, the structure-based drug discovery company pioneering the use of high throughput X-ray crystallography technology, today announced the...
Astex Announces Plans for New, Purpose-Built Facility on Cambridge Science Park
23 janv. 2002 07h46 HE
|
Astex Therapeutics
CAMBRIDGE, U.K., Jan. 23, 2002 (PRIMEZONE) -- Astex Technology, the structure-based drug discovery company pioneering the use of high throughput X-ray crystallography technology, today announced the...
Astex Raises an Additional 5.7m Pounds -- $8.1m US Dollars
17 déc. 2001 05h11 HE
|
Astex Therapeutics
CAMBRIDGE, U.K., Dec. 17, 2001 (PRIMEZONE) -- Astex Technology, the structure-based drug discovery company pioneering the use of high throughput X-ray crystallography (HTX(tm)) technology, today...
Astex Solves First Structure of a Human Cytochrome P450, A Key Enzyme in Drug Metabolism and Toxicity
17 déc. 2001 04h54 HE
|
Astex Therapeutics
CAMBRIDGE, U.K., Dec. 17, 2001 (PRIMEZONE) -- Astex Technology, the structure-based drug discovery company pioneering the use of high throughput X-ray crystallography (HTX(tm)) technology, today...
Astex Technology Appoints Jon S. Saxe to Board of Directors
20 nov. 2001 05h36 HE
|
Astex Therapeutics
CAMBRIDGE, UK, Nov. 20, 2001 (PRIMEZONE) -- Astex Technology, the UK structure-based drug discovery company, today announced the appointment of Jon Saxe to the Board.
Mr. Saxe was President of...